title: [Novelties in the pharmacological treatment of chronic heart failure].
abstract: Recently, results of several novel clinical trials on the pharmacological treatment of chronic heart failure have been published. In addition, the new European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure and a focused update by the ACC/AHA/HFSA on new pharmacological therapy for heart failure has been reported in 2016. This paper intends to provide an overview of the current state of the pharmacological treatment of chronic heart failure in the light of the new guidelines which incorporate the results of the new clinical trials. Orv. Hetil., 2016, 157(38), 1517-1521.
authors.affiliation: Kardiológiai Osztály, Magyar Honvédség Egészségügyi Központ Budapest, Róbert Károly krt. 44., 1134.
authors.forename: Noémi
authors.initials: N
authors.lastname: Nyolczas
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002309:Cardiology / Q000592:standards*; D002908:Chronic Disease; D006287:Health Planning Guidelines; D006333:Heart Failure / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D017410:Practice Guidelines as Topic; D024382:Professional Role; D012955:Societies, Medical / Q000592:standards
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors
keywords: chronic heart failure; diagnosis; diagnózis; guideline; irányelv; krónikus szívelégtelenség; terápia; therapy